Testing effectiveness (Phase 2)Ended earlyNCT03919162
What this trial is testing
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
Who this might be right for
Alzheimer Disease
Vivoryon Therapeutics N.V. 112
Showing 20 of 0 results